SurgTech Career LaunchPad
The aim of the free of charge event is to bring together Clinical Researchers, Surgery Professionals, and technology stakeholders to share barriers and solutions within the industry that will shape and deliver research into surgical technology
The virtual event will take place on Wednesday 8th June 2022 hosted by NIHR (National Institute for Health and Care Research) Incubator for Advanced Surgical Technologies powered by Empact Ventures.
It will feature Key Note Speakers (Stage), Roundtable Discussions (Sessions), PhD Clinic, Speed Video Networking, Expo Area, Live Chat and Polls. For those who register, attend and opt in you will receive 3 warm email introductions to potential collaborators that match your requirements facilitated after the event by the Empact Ventures team for those that attend.
It will also involve MedTech startups, scale-ups, and SMEs pitching and exhibiting in our MedTech Showcase welcoming new collaborations
Our Replay area will enable you to watch any recorded sessions you have missed during the event only and recordings will be posted on this page by mid-July 2022
NIHR (National Institute for Health and Care Research) Advanced Surgical Technology Incubator. The Incubator has been created to develop a vibrant, multi-disciplinary, advanced surgical technologies research community to realise the rapidly increasing potential of assistive, robotic and minimally-invasive surgery for the NHS. The Incubator will work to deliver its aims by providing inter-sectorial collaborations and engagement opportunities, resources and training activities for both clinical and non-clinical researchers in surgical technology.
Empact Ventures are super connectors who open the right doors at the right time to help the right people and organisations achieve the right mutual outcomes. We co-design some of the leading MedTech initiatives with healthcare organisations, universities and associations including the Market Access for MedTech course, Virtual Northern MedTech Summit, Super Connect for Good Competition and the Super Connect Series.
We are one of 11 Medtech and in-vitro diagnostics co-operatives (MICs) funded by the National Institute for Health Research (NIHR) to act as centres of expertise that focus on clinical areas of high morbidity and unmet need for NHS patients. Working collaboratively with patients and patient groups, charities, industry, clinicians and academics.
Videos of the Event:
Hosted by Kosta Mavroulakis (Founder & CEO, Empact Ventures) will give an introduction to Empact Ventures, the Hopin platform and the agenda for the event. This will be followed by an introduction by Martin Birchall (Director of the Advanced Surgical Technology Incubator and Professor of Laryngology at UCL) and Professor David Jayne (Clinical Director, NIHR Surgical MedTech Co-operative)
Professor Peter Thompson (Director of Programmes and Impact, NIHR Academy) will explain NIHR’s goals for supporting clinical researchers, its future strategy and how NIHR can help surgical team research careers.
This will feature five curated and selected MedTech startups,scale-ups and SMEs from across the UK, Ireland and Europe to present to the audience. They will be explaining the MedTech innovation they’ve developed, and their progress in going from academic research to commercialisation before outlining the development of their team and any career opportunities they currently have:
QV Bioelectronics (Manchester)
A pioneering medical device startup developing implanted technology for the next modality of cancer treatment, electric field therapy. They are developing cutting-edge technology with the aim of delivering transformative outcomes for Glioblastoma patients. Glioblastoma has some of the worst outcomes of any cancer, with 5-year survival rates <5%. Innovation in the space has been slow due to the complex nature of this cancer – meaning there are only 6 available FDA-approved therapies for this cancer. Comparatively, breast cancer has 61 FDA-approved treatment options. The founders, a biomedical engineer, and, a neurosurgeon, recognised this unmet need and combined their skills and expertise to develop the concept of the GRACE implant. Using an array of different sciences with an interdisciplinary approach, their talented and specialist team are striving towards delivering longer, better quality lives for brain tumour patients. Read More here
AZmed develops a leading computer-aided diagnosis tool powered by AI that detects all types of fractures in radiography. The first French CE-marked medical device in its category. Rayvolve is a computer-aided diagnosis tool designed by radiologists for radiologists to optimize their workflow without changing their habits. The software is capable of detecting fractures in standard X-rays. It has been clinically tested and has shown outstanding performance. There are 700+ practitioners concerned by Rayvolve, 1 million+ patients concerned by Rayvolve per year and 1 million X-rays collected for training Rayvolve. Read more here
Bowel (colorectal) cancer is the second most common cancer globally. It is the leading cause of cancer-related death in the Western world. Early diagnosis of bowel cancer significantly reduces the mortality rate. Current diagnostics tests such as colonoscopy or faecal blood detection kits can be invasive, unpleasant and expensive. CanSense is delivering an accurate, non-invasive, inexpensive blood test to diagnose bowel cancer early which is equivalent to a liquid biopsy for bowel cancer.They are using a label-free assay and combining laser spectroscopy with advanced data analytics. The development of a high throughput platform allows their diagnostic solution to be scalable. They continue to develop our product with large scale clinical studies. At CanSense the team ensures accuracy by utilising cutting-edge data analytics and machine learning to maximise the performance of our cancer diagnostic that reduces the need for invasive colonoscopy. As a University spin-out company they are dedicated to delivering our mission with full impact by bringing together leading scientists, clinicians and business expertise to deliver the rigour and requirements for diagnostic development. Read More here
MediSieve is a biotech company, developing “Magnetic Blood Filtration” (MBF), a combination of a device and a therapeutic platform for treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. From sepsis to malaria to leukaemia and viral infections, such as COVID-19, MediSieve has the ambition of providing hospitals with a tool to tackle some of mankind’s most serious diseases. The company’s first product is for the removal of IL-6 to treat patients experiencing hyper inflammation, including those suffering from sepsis, cytokine storms and COVID-19. The technology is pre-clinical, and MediSieve is currently raising £3.7M to support pivotal clinical trials. The company has recently been awarded a £1.55M grant from UKRI to trial the technology in COVID-19.
Mark Slack, Co-Founder & Chief Medical Officer at CMR Surgical. Mark will leverage his deep experience as a robotics surgeon and entrepreneur to visualise the evolving interface between the MedTech industry, the NHS and mutual support between theatre team researchers and industry R&D.
|Introduction to Roundtables and Discussion of specific career challenges to cross-cutting solutions.||Martin Birchall (Director of the Advanced Surgical Technology Incubator and Professor of Laryngology at UCL) outlines specific career challenges in cross-cutting solutions|
|Theatre Nurses||A speaker (TBC) will outline the challenges around Theatre Nurses|
|Early Career Surgeons||Josh Burke will introduce the key challenges around early career surgeons|
|Operating Department Practioner||This will session will introduce the key challenges around the Operating Department Practitioner (ODP)|
|Mid-Career Surgeons||Nick Hamilton (Academic Consultant ENT, University College London Hospital) will introduce the key challenges around Mid-Career Surgeons|
|Mentorship||This roundtable will discuss seeking mentors, how to mentor, and a proposal for a novel mentoring strategy. All attendees are invited to contribute and the session will also feature Peter Thompson, Director of Programmes and Impact, NIHR Academy|
|Exiting The Thesis||Even before starting a thesis, it is natural to be thinking about what is going to happen to you when it is written up, examined and published. Common worries include de-skilling, finding a job at an appropriate grade, and how to continue research in parallel with finishing training or carrying on within the existing career structures. This roundtable will ask some of these questions and others.
Speakers will include: Nick Hamilton (Academic Consultant ENT Surgeon, University College London Hospital) and Will Bolton (Clinical Research Fellow, University of Leeds)
|Finding Supervision||This roundtable will address the challenge of finding supervisors; the chicken-and-egg of finding the right research project and supervisor(s); what a great supervisor looks like; cross-disciplinary supervision. All attendees are invited to contribute
This session will be chaired by Martin Birchall (Director of the NIHR Incubator for Advanced Surgical Technologies)
|Early Independence||This roundtable will discuss the unique problems faced by post-doctoral clinical researchers trying to build research independence. All attendees invited to contribute|
|Industrial Partnership||This roundtable will discuss how the interface between the surgical MedTech industry and theatre teams could be improved, with specific reference to 2-way support, placements, joint funding and other ways of partnering. All attendees are invited to contribute.
Roundtable Speakers include: Professor Christi Deaton, Professor of Nursing, Department of Public Health & Primary Care, University of Cambridge School of Clinical Medicine, Cambridge University Hospitals
|PhD Clinic||This clinic is open to PhD students to share their challenges by going on video with expert advisors and industry organisations who can provide answers
Roundtable speakers include: Professor David Jayne (Clinical Director, NIHR Surgical MedTech Co-operative) and Josh Burke
Dr Dawn Carnes, Dawn Carnes, Professorial Research Fellow (University College of Osteopath) and Chair of the Council for Allied Health Professions in Research (CAHPR), will discuss how the Council for Allied health Professionals Research is working to change the UK health system structure and culture to transform future pathways for non-medical researchers
The Chairs from the Roundtable discussions will join together to discussion to solutions found within their sessions
The Digital Exhibition will provide you with an opportunity to connect with both MedTech SMEs and support organisations. It will enable you to view their support material and connect over video or text chat. You will be super connected by email with them if you select their ‘Super Connect Me’ button.
It will include:
- NIHR Surgical MedTech Co-operative
- NIHR Advanced Surgical Technology Incubator
- Empact Ventures
The Networking Area will provide you with an opportunity to super connect with other attendees on a one-to-one basis over video.
The short 3-minute sessions are randomly allocated by the Hopin Virtual Event Platform which can be extended for another 3-minutes, or you can move to the next person.
If you would like to super connect with that person, select the ‘Connect’ button to exchange contact details.
This will feature five curated and selected MedTech startups,scale-ups and SMEs from across the UK, Ireland and Europe to present to the audience. They will be explaining the MedTech innovation they've developed, and their progress in going from academic research to commercialisation before outlining the development of their team and any career opportunities they currently have
Director of Programmes and Impact | Executive Team | NIHR Academy
Professorial Research Fellow (University College of Osteopathy) and Chair of the Council for Allied Health Professions in Research (CAHPR),
Professor Mark Slack
Chief Medical Officer & Co-Founder, CMR Surgical
Professor Christi Deaton
Professor of Nursing, Department of Public Health & Primary Care, University of Cambridge School of Clinical Medicine, Cambridge University Hospitals
Professor David Jayne
Programme Director, NIHR Surgical MedTech Co-operative
Professor Martin Birchall
Director of the Advanced Surgical Technology Incubator and Professor of Laryngology at UCL
Association for Perioperative Practice (AfPP)
Academic Consultant ENT Surgeon at University College London Hospitals
Head of Marketing and Communication, AZmed
Dr Will Bolton,
NIHR Clinical Research Fellow, Global Health Research Group Surgical Technologie
Consultant Colorectal Surgeon @MFTnhs
Professor Dean Harris
Founder & Director, CanSense
Honorary Professor, Swansea University Medical School
Director of Nursing and Midwifery Research and Innovation Oxford Biomedical Research Centre
Head of Business Development, QV Bioelectronics
Edge Hill University
Founder and CEO – MediSieve Limited
Professor Kate Grafton
Professor of Allied Health Professions Education, Head of School of Health and Social Care, College of Social Science University of Lincoln
Clinical Research Fellow at The University of Leeds
Association for Perioperative Practice (AfPP)
Founder & CEO
Co-Founder & Host, SurgTech Career LaunchPad
Professor Manish Chand
Associate Professor of Surgery and Consultant Colorectal Surgeon at University College London
Please use the below form to register for the event on our Virtual Hopin Event Platform: